A court in Munich has granted a preliminary injunction that will prevent MSD from distributing the subcutaneous version of its cancer immunotherapy Keytruda in the German market. The verdict is the ...
MSD has fleshed out the results of phase 3 trials of its cholesterol-lowering, oral PCSK9 inhibitor, enlicitide decanoate, showing its efficacy was comparable to that of injectable alternatives. The ...
If you build engines, tune cars, or even just like mashing your foot on the throttle with conviction, you’ve probably heard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback